2012 Global H. Pylori Diagnostics Market Outlook: Test Volume and Sales Forecasts by Country and Market Segment
The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
Contains 208 pages and 9 tables
- Hospitals
- Physician Offices
- Commercial/Private Labs
- Public Health Labs
Contains 208 pages and 9 tables
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
Pathogenesis
Role in Peptic Ulcer Disease
Role in Gastric Cancer
Nonulcer Dyspepsia
B. Diagnostic Tests
C. Vaccines and Drugs
Specific Therapeutic Regimens
Who Should Be Treated?
Participants in Controlled Clinical Trials
Patients with Refractory Peptic Ulcer
Patients with Refractory NUD
Patients in High-Risk Groups for Gastric
Cancer
D. Instrumentation Review and Market Needs
Abbott AxSYM
Abbott IMx/IMx Select
Anagen AN2000/AuraFlex
Siemens Immuno 1
Beckman Coulter Access
BioChem Pharma/SR1
BioMerieux/Vitek Vidas
Biotrol System 7000
Chiron ACS: Centaur
Chiron ACS: 180
Siemens ELISA Processor II/III
Siemens/Opus/Plus/Magnum
Siemens Stratus
J&J Diagnostics Vitros ECi
J&J Diagnostics/Amersham Amerlite
Olympus PK310
Roche Elecsys 1010/2010
Roche Cobas Core
Roche ES 300/300AL
Roche ES 22
Roche ES 33
Tosoh AIA-1200/1200DX/NexIA/600
Wallac/Pharmacia Delfia
E. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Robotics
Temperature Cyclers
PCR Variations
Immuno-PCR
QC-PCR
DAP-PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Nucleic-Acid Sequence-Based
Strand Displacement Activation
Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassays
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio-Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene-Tec
Hemagen
Immunetics
Innogenetics
Inverness
J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
Pathogenesis
Role in Peptic Ulcer Disease
Role in Gastric Cancer
Nonulcer Dyspepsia
B. Diagnostic Tests
C. Vaccines and Drugs
Specific Therapeutic Regimens
Who Should Be Treated?
Participants in Controlled Clinical Trials
Patients with Refractory Peptic Ulcer
Patients with Refractory NUD
Patients in High-Risk Groups for Gastric
Cancer
D. Instrumentation Review and Market Needs
Abbott AxSYM
Abbott IMx/IMx Select
Anagen AN2000/AuraFlex
Siemens Immuno 1
Beckman Coulter Access
BioChem Pharma/SR1
BioMerieux/Vitek Vidas
Biotrol System 7000
Chiron ACS: Centaur
Chiron ACS: 180
Siemens ELISA Processor II/III
Siemens/Opus/Plus/Magnum
Siemens Stratus
J&J Diagnostics Vitros ECi
J&J Diagnostics/Amersham Amerlite
Olympus PK310
Roche Elecsys 1010/2010
Roche Cobas Core
Roche ES 300/300AL
Roche ES 22
Roche ES 33
Tosoh AIA-1200/1200DX/NexIA/600
Wallac/Pharmacia Delfia
E. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Robotics
Temperature Cyclers
PCR Variations
Immuno-PCR
QC-PCR
DAP-PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Nucleic-Acid Sequence-Based
Strand Displacement Activation
Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassays
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio-Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene-Tec
Hemagen
Immunetics
Innogenetics
Inverness
J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus
LIST OF TABLES
Major Companies Developing or Marketing Helicobacter Pylori Tests
France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Testing Market Sales by Major Supplier
Major Companies Developing or Marketing Helicobacter Pylori Tests
France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Testing Market Sales by Major Supplier